Location History:
- CM Utrecht, NL (2018 - 2021)
- Utrecht, NL (2024)
Company Filing History:
3 out of 48 
3 out of 27 Years Active: 2018-2024
Title: The Innovative Contributions of Jeffrey Matthijn Beekman
Introduction
Jeffrey Matthijn Beekman is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in relation to polycystic kidney disease. With a total of 3 patents, his work has the potential to impact the diagnosis and treatment of this condition.
Latest Patents
One of Beekman's latest patents is a rapid quantitative test designed to diagnose polycystic kidney disease. This invention relates to an assay that measures the swelling of organoids to diagnose diseases affecting fluid uptake or secretion. Another significant patent involves identifying drug candidates for treating polycystic kidney disease using organoids generated from primary cells. This assay also focuses on measuring organoid swelling to evaluate the effectiveness of potential treatments.
Career Highlights
Throughout his career, Beekman has worked with esteemed organizations such as UMC Utrecht Holding B.V. and the Royal Netherlands Academy of Arts and Sciences. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Beekman's notable coworkers include Johanna Florentia Dekkers and Cornelis Korstiaan Van Der Ent. Their collaborative efforts have further advanced the research and development of innovative diagnostic tools.
Conclusion
Jeffrey Matthijn Beekman's contributions to medical diagnostics, particularly in the realm of polycystic kidney disease, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to improving healthcare through innovation.